Molnupiravir Revisited-Critical Assessment of Studies in Animal Models of COVID-19
Description
Molnupiravir, a prodrug known for its broad antiviral activity, has demonstrated efficacy in animal models of COVID-19, prompting clinical trials, in which initial results indicated a significant effect against the disease. However, subsequent